» Articles » PMID: 18632783

The Impact of Sexual Dysfunction on the Quality of Life Measured by MSQoL-54 in Patients with Multiple Sclerosis

Overview
Journal Mult Scler
Publisher Sage Publications
Specialty Neurology
Date 2008 Jul 18
PMID 18632783
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Sexual dysfunction (SD) is a common but often overlooked symptom in multiple sclerosis (MS). The aim of this study was to estimate the frequency, type, and intensity of SD in our patients with MS and to investigate its influence on all the domains of quality of life.

Methods: The study population comprised a cohort of 109 patients with MS (McDonald's criteria, 2001). SD was quantified by a Szasz sexual functioning scale. Health-related quality of life was measured by a disease-specific instrument MSQoL-54 (Serbian version).

Results: The presence of at least one symptom of SD was found in about 84% of the men and in 85% of the women. The main complaints in women were reduced libido, difficulties in achieving orgasm, and decreased vaginal lubrication; in men, the main complaints were reduced libido, incomplete erections, and premature ejaculation. In women, statistically significant negative correlations between the presence and level of SD and quality of life domains were reached for all subscales (P < 0.01), except for the Pain subscale (P = 0.112). In men, negative correlations were also observed for all domains, but they were statistically significant for physical health, physical role limitations, social function, health distress, sexual function, and sexual function satisfaction (P < 0.01). We found that the presence of all the analyzed types of sexual problems statistically significantly lowered scores on the sexual function and the sexual function satisfaction subscales in both men and women (P < 0.01). The most prominent impact on both domains was observed for the total loss of erection in men and for anorgasmia in women.

Conclusions: Our results reveal that frequent occurrence of SD in MS patients prominently affects all aspects of their quality of life.

Citing Articles

Protocol for a randomised controlled feasibility trial of an integrated psychosexual intervention for sexual difficulties in people with Multiple Sclerosis: the PIMS trial.

Brown A, Norton S, Scott W, Barrett B, Rahman Q, Catterall L Pilot Feasibility Stud. 2025; 11(1):28.

PMID: 40069906 PMC: 11895209. DOI: 10.1186/s40814-025-01606-8.


Female sexual dysfunctions in multiple sclerosis patients with lower urinary tract symptoms: an Italian case-control study.

Balsamo R, Crocetto F, Barone B, Fusco F, Arcaniolo D, Costantini E Sex Med. 2024; 12(5):qfae054.

PMID: 39360228 PMC: 11443015. DOI: 10.1093/sexmed/qfae054.


Male sexual and reproductive health in multiple sclerosis: a scoping review.

Toljan K, Briggs F J Neurol. 2024; 271(5):2169-2181.

PMID: 38416171 PMC: 11055735. DOI: 10.1007/s00415-024-12250-2.


Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria.

Milanov I, Ivanova S, Tournev I, Chamova T, Kaprelyan A, Slavov G Rev Neurol. 2023; 77(s04):S1-S7.

PMID: 38018696 PMC: 10831698. DOI: 10.33588/rn.77s04.2023213.


Evaluation of sexual self-efficacy and sexual function in women with multiple sclerosis in Mashhad, Iran, in 2019: A cross-sectional study.

Manouchehri E, Saeedi M, Mirzaei Najmabadi K Curr J Neurol. 2023; 20(1):23-31.

PMID: 38011408 PMC: 8511602. DOI: 10.18502/cjn.v20i1.6376.